drugset / Trial / NCT02352311
Safety and Pharmacokinetic Characteristics of DKF-313
RandomizedCrossoverOpen-labelOther
Summary
This is a randomized, open-label, single-dose, 2-treatment, 2-way, 2-period crossover study to evaluate the safety and the pharmacokinetic characteristics of DKF-313 (dutasteride and tadalafil) in healthy male volunteers.
Timeline
- Start
- 2015-01
- Primary completion
- 2015-06
- Completion
- 2015-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Dutasteride | Small molecule | 0.5 mg | — |
| Subject | Tadalafil | Small molecule | 5 mg | — |